UK markets closed

Marchex, Inc. (MCHX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.36000.0000 (0.00%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 59.40M
Enterprise value 46.90M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.29
Price/book (mrq)1.66
Enterprise value/revenue 0.94
Enterprise value/EBITDA -8.30

Trading information

Stock price history

Beta (5Y monthly) 1.97
52-week change 3-25.27%
S&P500 52-week change 322.38%
52-week high 32.2000
52-week low 31.1100
50-day moving average 31.3470
200-day moving average 31.4556

Share statistics

Avg vol (3-month) 374.52k
Avg vol (10-day) 327.98k
Shares outstanding 539.02M
Implied shares outstanding 643.68M
Float 811.67M
% held by insiders 17.69%
% held by institutions 166.72%
Shares short (15 Apr 2024) 4118.33k
Short ratio (15 Apr 2024) 41.65
Short % of float (15 Apr 2024) 40.56%
Short % of shares outstanding (15 Apr 2024) 40.27%
Shares short (prior month 15 Mar 2024) 4103.55k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 41.58
Payout ratio 40.00%
Dividend date 321 Mar 2018
Ex-dividend date 407 Mar 2018
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -19.86%
Operating margin (ttm)-9.05%

Management effectiveness

Return on assets (ttm)-11.55%
Return on equity (ttm)-24.78%

Income statement

Revenue (ttm)49.91M
Revenue per share (ttm)1.17
Quarterly revenue growth (yoy)0.80%
Gross profit (ttm)N/A
EBITDA -5.76M
Net income avi to common (ttm)-9.91M
Diluted EPS (ttm)-0.2300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)14.61M
Total cash per share (mrq)0.34
Total debt (mrq)2.31M
Total debt/equity (mrq)6.44%
Current ratio (mrq)2.45
Book value per share (mrq)0.84

Cash flow statement

Operating cash flow (ttm)-4.39M
Levered free cash flow (ttm)-1.86M